US Stock MarketDetailed Quotes

EPIRUS Biopharmaceuticals, Inc. (EPRSQ)

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose May 13 16:00 ET
26.18Market Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EPIRUS Biopharmaceuticals, Inc. (EPRSQ) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2016
(FY)Dec 31, 2015
(Q4)Dec 31, 2015
(Q3)Sep 30, 2015
(Q2)Jun 30, 2015
(Q1)Mar 31, 2015
(FY)Dec 31, 2014
(Q4)Dec 31, 2014
(Q3)Sep 30, 2014
(Q2)Jun 30, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.64%-10.62M
-31.33%-46.58M
-102.99%-16.46M
26.16%-11.29M
-25.91%-10.65M
-126.44%-8.19M
-175.43%-35.47M
-108.57%-8.11M
-337.88%-15.29M
-26.13%-8.46M
Net income from continuing operations
-116.27%-16.27M
-24.72%-52.19M
-48.03%-15.39M
-0.37%-13.99M
-54.54%-15.29M
1.29%-7.52M
-101.22%-41.84M
-33.78%-10.4M
-349.42%-13.94M
6.35%-9.89M
Operating gains losses
----
-6,372.73%-1.42M
---1.42M
---8K
----
----
---22K
--0
--0
----
Depreciation and amortization
198.96%287K
261.82%597K
201.01%298K
144.44%110K
745.45%93K
860.00%96K
432.26%165K
1,000.00%99K
100.90%45K
-99.56%11K
Deferred tax
0.00%-46K
-228.65%-608K
-38.30%-65K
-880.43%-451K
0.00%-46K
0.00%-46K
-1,056.25%-185K
-335.00%-47K
---46K
---46K
Other non cash items
-59.84%51K
-94.05%153K
-215.33%-173K
-12.68%62K
-88.12%137K
-89.38%127K
-47.68%2.57M
-95.86%150K
-95.27%71K
1,167.59%1.15M
Change In working capital
347.18%3.24M
-17.22%1.58M
-164.63%-1.09M
115.18%363K
4,255.17%3.62M
-148.61%-1.31M
-7.57%1.91M
746.73%1.69M
-151.62%-2.39M
-109.83%-87K
-Change in prepaid assets
295.28%703K
-618.12%-1.98M
-673.07%-1.85M
-135.09%-402K
196.19%631K
-257.89%-360K
-360.00%-276K
146.56%323K
-211.76%-171K
-220.00%-656K
-Change in payables and accrued expense
153.02%649K
25.35%2.07M
-86.25%229K
162.03%1.43M
188.16%1.63M
-171.00%-1.22M
-24.11%1.65M
4,284.21%1.67M
-164.39%-2.31M
-67.15%566K
-Change in other working capital
595.22%1.89M
180.45%1.49M
256.91%477K
-809.30%-610K
45,000.00%1.35M
-63.59%272K
1,123.08%532K
-1,113.33%-304K
-94.67%86K
100.36%3K
Cash from discontinued investing activities
Operating cash flow
-29.64%-10.62M
-31.33%-46.58M
-102.99%-16.46M
26.16%-11.29M
-25.91%-10.65M
-126.44%-8.19M
-175.43%-35.47M
-108.57%-8.11M
-337.88%-15.29M
-26.13%-8.46M
Investing cash flow
Cash flow from continuing investing activities
-70K
-93.16%841K
362.09%3.53M
-119.35%-2.65M
-130.00%-46K
0
14,394.19%12.29M
-33,600.00%-1.35M
198.61%13.68M
-100.42%-20K
Net PPE purchase and sale
---70K
-123.94%-477K
-259.18%-352K
1.25%-79K
----
----
-147.67%-213K
-2,350.00%-98K
-206.67%-80K
86.21%-20K
Net intangibles purchase and sale
----
406.32%3.83M
----
----
----
----
---1.25M
----
----
----
Net business purchase and sale
----
-118.25%-2.51M
--56K
----
----
----
--13.76M
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---70K
-93.16%841K
362.09%3.53M
-119.35%-2.65M
-130.00%-46K
--0
14,394.19%12.29M
-33,600.00%-1.35M
198.61%13.68M
-100.42%-20K
Financing cash flow
Cash flow from continuing financing activities
-99.96%18K
30.29%55.82M
-99.49%37K
125.35%73K
-75.87%7.44M
849.86%48.27M
241.96%42.84M
44.75%7.24M
-103.81%-288K
1,909.85%30.81M
Net issuance payments of debt
----
-38.95%7.5M
--0
--0
----
----
-1.72%12.29M
45.70%7.29M
--0
--0
Net common stock issuance
-99.96%18K
16,248.82%47.96M
--0
--0
---65K
--48.03M
-14,950.00%-297K
--0
----
----
Net preferred stock issuance
----
----
----
31,700.00%318K
----
----
616,140.00%30.81M
--0
--1K
----
Proceeds from stock option exercised by employees
----
294.44%355K
----
----
--0
198.78%245K
328.57%90K
--0
-42.86%8K
--0
Net other financing activities
----
----
----
----
----
----
---49K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-99.96%18K
30.29%55.82M
-99.49%37K
125.35%73K
-75.87%7.44M
849.86%48.27M
241.96%42.84M
44.75%7.24M
-103.81%-288K
1,909.85%30.81M
Net cash flow
Beginning cash position
46.84%31.52M
1,093.66%21.46M
87.59%44.42M
127.83%58.29M
1,794.31%61.55M
1,093.66%21.46M
-19.52%1.8M
3,332.03%23.68M
793.30%25.58M
0.87%3.25M
Current changes in cash
-126.61%-10.67M
-48.76%10.08M
-480.71%-12.89M
-628.53%-13.86M
-114.59%-3.26M
2,662.51%40.08M
4,610.09%19.66M
-300.27%-2.22M
-1,726.50%-1.9M
6,409.32%22.34M
Effect of exchange rate changes
--17K
---23K
----
----
----
----
----
----
----
----
End cash Position
-66.10%20.87M
46.84%31.52M
46.84%31.52M
87.59%44.42M
127.83%58.29M
1,794.31%61.55M
1,093.66%21.46M
1,093.66%21.46M
3,332.03%23.68M
793.30%25.58M
Free cash flow
-30.50%-10.69M
-27.40%-47.06M
-77.69%-16.81M
26.03%-11.37M
-26.16%-10.69M
-125.50%-8.19M
-184.92%-36.94M
-143.10%-9.46M
-336.37%-15.37M
-23.76%-8.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2016(FY)Dec 31, 2015(Q4)Dec 31, 2015(Q3)Sep 30, 2015(Q2)Jun 30, 2015(Q1)Mar 31, 2015(FY)Dec 31, 2014(Q4)Dec 31, 2014(Q3)Sep 30, 2014(Q2)Jun 30, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.64%-10.62M-31.33%-46.58M-102.99%-16.46M26.16%-11.29M-25.91%-10.65M-126.44%-8.19M-175.43%-35.47M-108.57%-8.11M-337.88%-15.29M-26.13%-8.46M
Net income from continuing operations -116.27%-16.27M-24.72%-52.19M-48.03%-15.39M-0.37%-13.99M-54.54%-15.29M1.29%-7.52M-101.22%-41.84M-33.78%-10.4M-349.42%-13.94M6.35%-9.89M
Operating gains losses -----6,372.73%-1.42M---1.42M---8K-----------22K--0--0----
Depreciation and amortization 198.96%287K261.82%597K201.01%298K144.44%110K745.45%93K860.00%96K432.26%165K1,000.00%99K100.90%45K-99.56%11K
Deferred tax 0.00%-46K-228.65%-608K-38.30%-65K-880.43%-451K0.00%-46K0.00%-46K-1,056.25%-185K-335.00%-47K---46K---46K
Other non cash items -59.84%51K-94.05%153K-215.33%-173K-12.68%62K-88.12%137K-89.38%127K-47.68%2.57M-95.86%150K-95.27%71K1,167.59%1.15M
Change In working capital 347.18%3.24M-17.22%1.58M-164.63%-1.09M115.18%363K4,255.17%3.62M-148.61%-1.31M-7.57%1.91M746.73%1.69M-151.62%-2.39M-109.83%-87K
-Change in prepaid assets 295.28%703K-618.12%-1.98M-673.07%-1.85M-135.09%-402K196.19%631K-257.89%-360K-360.00%-276K146.56%323K-211.76%-171K-220.00%-656K
-Change in payables and accrued expense 153.02%649K25.35%2.07M-86.25%229K162.03%1.43M188.16%1.63M-171.00%-1.22M-24.11%1.65M4,284.21%1.67M-164.39%-2.31M-67.15%566K
-Change in other working capital 595.22%1.89M180.45%1.49M256.91%477K-809.30%-610K45,000.00%1.35M-63.59%272K1,123.08%532K-1,113.33%-304K-94.67%86K100.36%3K
Cash from discontinued investing activities
Operating cash flow -29.64%-10.62M-31.33%-46.58M-102.99%-16.46M26.16%-11.29M-25.91%-10.65M-126.44%-8.19M-175.43%-35.47M-108.57%-8.11M-337.88%-15.29M-26.13%-8.46M
Investing cash flow
Cash flow from continuing investing activities -70K-93.16%841K362.09%3.53M-119.35%-2.65M-130.00%-46K014,394.19%12.29M-33,600.00%-1.35M198.61%13.68M-100.42%-20K
Net PPE purchase and sale ---70K-123.94%-477K-259.18%-352K1.25%-79K---------147.67%-213K-2,350.00%-98K-206.67%-80K86.21%-20K
Net intangibles purchase and sale ----406.32%3.83M-------------------1.25M------------
Net business purchase and sale -----118.25%-2.51M--56K--------------13.76M--0--------
Cash from discontinued investing activities
Investing cash flow ---70K-93.16%841K362.09%3.53M-119.35%-2.65M-130.00%-46K--014,394.19%12.29M-33,600.00%-1.35M198.61%13.68M-100.42%-20K
Financing cash flow
Cash flow from continuing financing activities -99.96%18K30.29%55.82M-99.49%37K125.35%73K-75.87%7.44M849.86%48.27M241.96%42.84M44.75%7.24M-103.81%-288K1,909.85%30.81M
Net issuance payments of debt -----38.95%7.5M--0--0---------1.72%12.29M45.70%7.29M--0--0
Net common stock issuance -99.96%18K16,248.82%47.96M--0--0---65K--48.03M-14,950.00%-297K--0--------
Net preferred stock issuance ------------31,700.00%318K--------616,140.00%30.81M--0--1K----
Proceeds from stock option exercised by employees ----294.44%355K----------0198.78%245K328.57%90K--0-42.86%8K--0
Net other financing activities ---------------------------49K------------
Cash from discontinued financing activities
Financing cash flow -99.96%18K30.29%55.82M-99.49%37K125.35%73K-75.87%7.44M849.86%48.27M241.96%42.84M44.75%7.24M-103.81%-288K1,909.85%30.81M
Net cash flow
Beginning cash position 46.84%31.52M1,093.66%21.46M87.59%44.42M127.83%58.29M1,794.31%61.55M1,093.66%21.46M-19.52%1.8M3,332.03%23.68M793.30%25.58M0.87%3.25M
Current changes in cash -126.61%-10.67M-48.76%10.08M-480.71%-12.89M-628.53%-13.86M-114.59%-3.26M2,662.51%40.08M4,610.09%19.66M-300.27%-2.22M-1,726.50%-1.9M6,409.32%22.34M
Effect of exchange rate changes --17K---23K--------------------------------
End cash Position -66.10%20.87M46.84%31.52M46.84%31.52M87.59%44.42M127.83%58.29M1,794.31%61.55M1,093.66%21.46M1,093.66%21.46M3,332.03%23.68M793.30%25.58M
Free cash flow -30.50%-10.69M-27.40%-47.06M-77.69%-16.81M26.03%-11.37M-26.16%-10.69M-125.50%-8.19M-184.92%-36.94M-143.10%-9.46M-336.37%-15.37M-23.76%-8.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -